
A new pill reduced artery-clogging cholesterol in people who remain at high risk of heart attacks, despite taking medication, a new study has found.
The new enlicitid pill, still in experimental phases, reduced levels of low-density lipoprotein (LDL), commonly known as “bad” cholesterol, by up to 60 percent, according to a study published in the New England Journal of Medicine.